{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:03:35Z","timestamp":1792213415411,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7684","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/nature25016","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T05:25:39Z","timestamp":1512537939000},"page":"194-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":786,"title":["Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4"],"prefix":"10.1038","volume":"552","author":[{"given":"Zdenek","family":"Skrott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mistrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Kaae","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusana","family":"Majera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ozdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirina","family":"Bartkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Turi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Moudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Michalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Vaclavkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Dzubak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Vrobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Pouckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindrich","family":"Sedlacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Miklovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Mattova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q. Ping","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Hajduch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Cvek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Deshaies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"BFnature25016_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrd3461","volume":"10","author":"FS Collins","year":"2011","unstructured":"Collins, F. S. Mining for therapeutic gold. Nat. Rev. Drug Discov. 10, 397 (2011)","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnature25016_CR2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3332\/ecancer.2014.485","volume":"8","author":"P Pantziarka","year":"2014","unstructured":"Pantziarka, P. et al. The repurposing drugs in oncology (ReDO) project. Ecancermedicalscience 8, 442 (2014)","journal-title":"Ecancermedicalscience"},{"key":"BFnature25016_CR3","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-09-1035","volume":"15","author":"K Iljin","year":"2009","unstructured":"Iljin, K. et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin. Cancer Res. 15, 6070\u20136078 (2009)","journal-title":"Clin. Cancer Res."},{"key":"BFnature25016_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.drudis.2011.12.010","volume":"17","author":"B Cvek","year":"2012","unstructured":"Cvek, B. Nonprofit drugs as the salvation of the world\u2019s healthcare systems: the case of Antabuse (disulfiram). Drug Discov. Today 17, 409\u2013412 (2012)","journal-title":"Drug Discov. Today"},{"key":"BFnature25016_CR5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0006-2952(00)00586-4","volume":"61","author":"ML Shen","year":"2001","unstructured":"Shen, M. L., Johnson, K. L., Mays, D. C., Lipsky, J. J. & Naylor, S. Determination of in vivo adducts of disulfiram with mitochondrial aldehyde dehydrogenase. Biochem. Pharmacol. 61, 537\u2013545 (2001)","journal-title":"Biochem. Pharmacol."},{"key":"BFnature25016_CR6","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","volume":"66","author":"D Chen","year":"2006","unstructured":"Chen, D., Cui, Q. C., Yang, H. & Dou, Q. P. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 66, 10425\u201310433 (2006)","journal-title":"Cancer Res."},{"key":"BFnature25016_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1479-5876-12-163","volume":"12","author":"J Zha","year":"2014","unstructured":"Zha, J. et al. Disulfiram targeting lymphoid malignant cell lines via ROS\u2013JNK activation as well as Nrf2 and NF-\u03baB pathway inhibition. J. Transl. Med. 12, 163 (2014)","journal-title":"J. Transl. Med."},{"key":"BFnature25016_CR8","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1158\/0008-5472.CAN-13-3527","volume":"74","author":"R Safi","year":"2014","unstructured":"Safi, R. et al. Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 74, 5819\u20135831 (2014)","journal-title":"Cancer Res."},{"key":"BFnature25016_CR9","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.18632\/oncotarget.2166","volume":"5","author":"P Liu","year":"2014","unstructured":"Liu, P. et al. Liposome encapsulated disulfiram inhibits NF\u03baB pathway and targets breast cancer stem cells in vitro and in vivo. Oncotarget 5, 7471\u20137485 (2014)","journal-title":"Oncotarget"},{"key":"BFnature25016_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01877380","volume":"6","author":"P Dufour","year":"1993","unstructured":"Dufour, P. et al. Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy 6, 9\u201312 (1993)","journal-title":"Biotherapy"},{"key":"BFnature25016_CR11","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","volume":"104","author":"NC Yip","year":"2011","unstructured":"Yip, N. C. et al. Disulfiram modulated ROS\u2013MAPK and NF\u03baB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br. J. Cancer 104, 1564\u20131574 (2011)","journal-title":"Br. J. Cancer"},{"key":"BFnature25016_CR12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ijc.21534","volume":"118","author":"H L\u00f6vborg","year":"2006","unstructured":"L\u00f6vborg, H. et al. Inhibition of proteasome activity, nuclear factor-\u03baB translocation and cell survival by the antialcoholism drug disulfiram. Int. J. Cancer 118, 1577\u20131580 (2006)","journal-title":"Int. J. Cancer"},{"key":"BFnature25016_CR13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.molonc.2015.02.007","volume":"9","author":"JL Allensworth","year":"2015","unstructured":"Allensworth, J. L. et al. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. Mol. Oncol. 9, 1155\u20131168 (2015)","journal-title":"Mol. Oncol."},{"key":"BFnature25016_CR14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","volume":"20","author":"H Nechushtan","year":"2015","unstructured":"Nechushtan, H. et al. A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. Oncologist 20, 366\u2013367 (2015)","journal-title":"Oncologist"},{"key":"BFnature25016_CR15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/annonc\/mds508","volume":"24","author":"M Jin","year":"2013","unstructured":"Jin, M. et al. Alcohol drinking and all cancer mortality: a meta-analysis. Ann. Oncol. 24, 807\u2013816 (2013)","journal-title":"Ann. Oncol."},{"key":"BFnature25016_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2015.07.029","volume":"369","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Copper improves the anti-angiogenic activity of disulfiram through the EGFR\/Src\/VEGF pathway in gliomas. Cancer Lett. 369, 86\u201396 (2015)","journal-title":"Cancer Lett."},{"key":"BFnature25016_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0304-4165(97)00027-5","volume":"1335","author":"Y Suzuki","year":"1997","unstructured":"Suzuki, Y. et al. The origin of an EPR signal observed in dithiocarbamate-loaded tissues. Copper(ii)-dithiocarbamate complexes account for the narrow hyperfine lines. Biochim. Biophys. Acta 1335, 242\u2013245 (1997)","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnature25016_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrd3373","volume":"10","author":"O Kepp","year":"2011","unstructured":"Kepp, O., Galluzzi, L., Lipinski, M., Yuan, J. & Kroemer, G. Cell death assays for drug discovery. Nat. Rev. Drug Discov. 10, 221\u2013237 (2011)","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnature25016_CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2008.12.041","volume":"136","author":"C Doil","year":"2009","unstructured":"Doil, C. et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136, 435\u2013446 (2009)","journal-title":"Cell"},{"key":"BFnature25016_CR20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/MCB.01190-13","volume":"34","author":"JM Li","year":"2014","unstructured":"Li, J. M., Wu, H., Zhang, W., Blackburn, M. R. & Jin, J. The p97\u2013UFD1L\u2013NPL4 protein complex mediates cytokine-induced I\u03baB\u03b1 proteolysis. Mol. Cell. Biol. 34, 335\u2013347 (2014)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature25016_CR21","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.M110.215319","volume":"286","author":"TF Chou","year":"2011","unstructured":"Chou, T. F. & Deshaies, R. J. Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin\u2013proteasome system. J. Biol. Chem. 286, 16546\u201316554 (2011)","journal-title":"J. Biol. Chem."},{"key":"BFnature25016_CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0076-6879(05)98030-0","volume":"398","author":"AF Kisselev","year":"2005","unstructured":"Kisselev, A. F. & Goldberg, A. L. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol. 398, 364\u2013378 (2005)","journal-title":"Methods Enzymol."},{"key":"BFnature25016_CR23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1073\/pnas.98.3.1188","volume":"98","author":"G Asher","year":"2001","unstructured":"Asher, G ., Lotem, J ., Cohen, B ., Sachs, L. & Shaul, Y. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl Acad. Sci. USA 98, 1188\u20131193 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature25016_CR24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gad.319905","volume":"19","author":"G Asher","year":"2005","unstructured":"Asher, G ., Tsvetkov, P ., Kahana, C. & Shaul, Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 19, 316\u2013321 (2005)","journal-title":"Genes Dev."},{"key":"BFnature25016_CR25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.1075898","volume":"298","author":"R Verma","year":"2002","unstructured":"Verma, R. et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298, 611\u2013615 (2002)","journal-title":"Science"},{"key":"BFnature25016_CR26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35087056","volume":"3","author":"RM Dai","year":"2001","unstructured":"Dai, R. M. & Li, C. C. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin\u2013proteasome degradation. Nat. Cell Biol. 3, 740\u2013744 (2001)","journal-title":"Nat. Cell Biol."},{"key":"BFnature25016_CR27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cell.2008.06.048","volume":"134","author":"G Alexandru","year":"2008","unstructured":"Alexandru, G . et al. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1\u03b1 turnover. Cell 134, 804\u2013816 (2008)","journal-title":"Cell"},{"key":"BFnature25016_CR28","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.1015312108","volume":"108","author":"TF Chou","year":"2011","unstructured":"Chou, T. F. et al. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl Acad. Sci. USA 108, 4834\u20134839 (2011)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature25016_CR29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/cc.27779","volume":"13","author":"A Riemer","year":"2014","unstructured":"Riemer, A. et al. The p97\u2013Ufd1\u2013Npl4 ATPase complex ensures robustness of the G2\/M checkpoint by facilitating CDC25A degradation. Cell Cycle 13, 919\u2013927 (2014)","journal-title":"Cell Cycle"},{"key":"BFnature25016_CR30","doi-asserted-by":"crossref","first-page":"e01856","DOI":"10.7554\/eLife.01856","volume":"3","author":"SK Radhakrishnan","year":"2014","unstructured":"Radhakrishnan, S. K., den Besten, W. & Deshaies, R. J. p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition. eLife 3, e01856 (2014)","journal-title":"eLife"},{"key":"BFnature25016_CR31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ncb2407","volume":"14","author":"H Meyer","year":"2012","unstructured":"Meyer, H., Bug, M. & Bremer, S. Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14, 117\u2013123 (2012)","journal-title":"Nat. Cell Biol."},{"key":"BFnature25016_CR32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nchembio.1313","volume":"9","author":"P Magnaghi","year":"2013","unstructured":"Magnaghi, P. et al. Covalent and allosteric inhibitors of the ATPase VCP\/p97 induce cancer cell death. Nat. Chem. Biol. 9, 548\u2013556 (2013)","journal-title":"Nat. Chem. Biol."},{"key":"BFnature25016_CR33","first-page":"830307","volume":"2010","author":"A Samali","year":"2010","unstructured":"Samali, A., Fitzgerald, U., Deegan, S. & Gupta, S. Methods for monitoring endoplasmic reticulum stress and the unfolded protein response. Int. J. Cell Biol. 2010, 830307 (2010)","journal-title":"Int. J. Cell Biol."},{"key":"BFnature25016_CR34","doi-asserted-by":"crossref","first-page":"e74415","DOI":"10.1371\/journal.pone.0074415","volume":"8","author":"HW Auner","year":"2013","unstructured":"Auner, H. W. et al. Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells. PLoS ONE 8, e74415 (2013)","journal-title":"PLoS ONE"},{"key":"BFnature25016_CR35","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/leu.2016.102","volume":"30","author":"GP Soriano","year":"2016","unstructured":"Soriano, G. P. et al. Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism. Leukemia 30, 2198\u20132207 (2016)","journal-title":"Leukemia"},{"key":"BFnature25016_CR36","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.yexcr.2008.06.008","volume":"314","author":"A Lass","year":"2008","unstructured":"Lass, A., McConnell, E., Fleck, K., Palamarchuk, A. & W\u00f3jcik, C. Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD. Exp. Cell Res. 314, 2715\u20132723 (2008)","journal-title":"Exp. Cell Res."},{"key":"BFnature25016_CR37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pep.2011.04.022","volume":"79","author":"I Vor\u00e1c\u02c7kov\u00e1","year":"2011","unstructured":"Vor\u00e1c\u02c7kov\u00e1, I., Suchanov\u00e1, S., Ulbrich, P., Diehl, W. E. & Ruml, T. Purification of proteins containing zinc finger domains using immobilized metal ion affinity chromatography. Protein Expr. Purif. 79, 88\u201395 (2011)","journal-title":"Protein Expr. Purif."},{"key":"BFnature25016_CR38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-62703-398-5_12","volume":"1008","author":"G Holdgate","year":"2013","unstructured":"Holdgate, G. et al. Biophysical methods in drug discovery from small molecule to pharmaceutical. Methods Mol. Biol. 1008, 327\u2013355 (2013)","journal-title":"Methods Mol. Biol."},{"key":"BFnature25016_CR39","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick, B. et al. Target identification using drug affinity responsive target stability (DARTS). Proc. Natl Acad. Sci. USA 106, 21984\u201321989 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature25016_CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker, L. A. et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544, 367\u2013371 (2017)","journal-title":"Nature"},{"key":"BFnature25016_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2014.04.030","volume":"55","author":"L Guo","year":"2014","unstructured":"Guo, L. et al. A cellular system that degrades misfolded proteins and protects against neurodegeneration. Mol. Cell 55, 15\u201330 (2014)","journal-title":"Mol. Cell"},{"key":"BFnature25016_CR42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","volume":"82","author":"YE Kim","year":"2013","unstructured":"Kim, Y. E., Hipp, M. S., Bracher, A., Hayer-Hartl, M. & Hartl, F. U. Molecular chaperone functions in protein folding and proteostasis. Annu. Rev. Biochem. 82, 323\u2013355 (2013)","journal-title":"Annu. Rev. Biochem."},{"key":"BFnature25016_CR43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tcb.2015.10.011","volume":"26","author":"C Dai","year":"2016","unstructured":"Dai, C. & Sampson, S. B. HSF1: guardian of proteostasis in cancer. Trends Cell Biol. 26, 17\u201328 (2016)","journal-title":"Trends Cell Biol."},{"key":"BFnature25016_CR44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/156800911794519806","volume":"11","author":"B Cvek","year":"2011","unstructured":"Cvek, B. Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome. Curr. Cancer Drug Targets 11, 332\u2013337 (2011)","journal-title":"Curr. Cancer Drug Targets"},{"key":"BFnature25016_CR45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12915-014-0094-0","volume":"12","author":"RJ Deshaies","year":"2014","unstructured":"Deshaies, R. J. Proteotoxic crisis, the ubiquitin\u2013proteasome system, and cancer therapy. BMC Biol. 12, 94 (2014)","journal-title":"BMC Biol."},{"key":"BFnature25016_CR46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2015.10.002","volume":"28","author":"DJ Anderson","year":"2015","unstructured":"Anderson, D. J . et al. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell 28, 653\u2013665 (2015)","journal-title":"Cancer Cell"},{"key":"BFnature25016_CR47","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1007\/s13277-015-3748-9","volume":"36","author":"Y Cui","year":"2015","unstructured":"Cui, Y. et al. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma. Tumour Biol. 36, 9919\u20139927 (2015)","journal-title":"Tumour Biol."},{"key":"BFnature25016_CR48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/1078-0432.CCR-1576-03","volume":"10","author":"S Yamamoto","year":"2004","unstructured":"Yamamoto, S. et al. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin. Cancer Res. 10, 651\u2013657 (2004)","journal-title":"Clin. Cancer Res."},{"key":"BFnature25016_CR49","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/1078-0432.CCR-03-0191","volume":"10","author":"Y Tsujimoto","year":"2004","unstructured":"Tsujimoto, Y. et al. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin. Cancer Res. 10, 3007\u20133012 (2004)","journal-title":"Clin. Cancer Res."},{"key":"BFnature25016_CR50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1403494811399956","volume":"39","author":"LC Thygesen","year":"2011","unstructured":"Thygesen, L. C., Daasnes, C., Thaulow, I. & Br\u00f8nnum-Hansen, H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand. J. Public Health 39 (Suppl), 12\u201316 (2011)","journal-title":"Scand. J. Public Health"},{"key":"BFnature25016_CR51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum, P. R. & Rubin, D. B. The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41\u201355 (1983)","journal-title":"Biometrika"},{"key":"BFnature25016_CR52","unstructured":"R Core Team . R: A language and environment for statistical computing. R Foundation for Statistical Computinghttps:\/\/www.R-project.org\/ R v.3.2.3 (2015-12-10) (R Foundation for Statistical Computing, 2016)"},{"key":"BFnature25016_CR53","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1021\/jm8007807","volume":"51","author":"B Cvek","year":"2008","unstructured":"Cvek, B., Milacic, V., Taraba, J. & Dou, Q. P. Ni(ii), Cu(ii), and Zn(ii) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. J. Med. Chem. 51, 6256\u20136258 (2008)","journal-title":"J. Med. Chem."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature25016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature25016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature25016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature25016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:10:01Z","timestamp":1684419001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature25016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":53,"journal-issue":{"issue":"7684","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFnature25016"],"URL":"https:\/\/doi.org\/10.1038\/nature25016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732234310.793542168","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732234310.793542074","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"1 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.J.D. is a founder of and consultant for Cleave Biosciences. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}